Drug application
RENOGRAFIN-76 (DIATRIZOATE MEGLUMINE, DIATRIZOATE SODIUM)
Drugs@FDA NDA 010040 · BRACCO
Key facts
| Drug name | RENOGRAFIN-76 |
|---|---|
| Active ingredients | DIATRIZOATE MEGLUMINE, DIATRIZOATE SODIUM |
| Application type | NDA |
| Application number | 010040 |
| Company | BRACCO |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 66%;10% |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 2 New Active Ingredient and Type 4 New Combination |
| Latest submission status date | Aug 2, 1955 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 1–9 Label versions
- 10–99 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: